Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465M Buy
3,614,905
+835,799
+30% +$97.8M 0.15% 122
2026
Q1
$334M Buy
2,779,106
+142,995
+5% +$16.5M 0.14% 137
2025
Q4
$277M Sell
2,636,111
-1,886,279
-42% -$177M 0.12% 141
2025
Q3
$380M Sell
4,522,390
-585,368
-11% -$48.2M 0.17% 106
2025
Q2
$404M Sell
5,107,758
-1,124,836
-18% -$89.4M 0.2% 92
2025
Q1
$559M Buy
6,232,594
+1,492,688
+31% +$139M 0.29% 51
2024
Q4
$472M Buy
4,739,906
+317,713
+7% +$32.8M 0.28% 60
2024
Q3
$502M Sell
4,422,193
-2,234,741
-34% -$265M 0.29% 61
2024
Q2
$824M Buy
6,656,934
+1,946,873
+41% +$251M 0.53% 28
2024
Q1
$621M Buy
4,710,061
+613,098
+15% +$75.6M 0.41% 35
2023
Q4
$447M Sell
4,096,963
-104,673
-2% -$10.9M 0.31% 49
2023
Q3
$433M Buy
4,201,636
+157,988
+4% +$17M 0.32% 44
2023
Q2
$467M Sell
4,043,648
-26,736
-0.7% -$3.04M 0.31% 42
2023
Q1
$433M Buy
4,070,384
+301,346
+8% +$32.5M 0.3% 46
2022
Q4
$418M Buy
3,769,038
+65,347
+2% +$6.68M 0.33% 47
2022
Q3
$319M Sell
3,703,691
-207,836
-5% -$18.6M 0.23% 72
2022
Q2
$357M Sell
3,911,527
-55,163
-1% -$4.89M 0.27% 56
2022
Q1
$325M Sell
3,966,690
-815,476
-17% -$64.3M 0.2% 78
2021
Q4
$367M Buy
4,782,166
+295,895
+7% +$23.6M 0.2% 83
2021
Q3
$337M Sell
4,486,271
-615,603
-12% -$46.8M 0.2% 78
2021
Q2
$397M Sell
5,101,874
-206,260
-4% -$15.3M 0.24% 75
2021
Q1
$390M Buy
5,308,134
+698,071
+15% +$51.5M 0.25% 75
2020
Q4
$360M Buy
4,610,063
+415,833
+10% +$31.8M 0.21% 80
2020
Q3
$332M Buy
4,194,230
+35,087
+0.8% +$2.75M 0.22% 71
2020
Q2
$307M Buy
4,159,143
+909,542
+28% +$68.5M 0.24% 59
2020
Q1
$239M Buy
3,249,601
+25,308
+0.8% +$1.99M 0.22% 69
2019
Q4
$280M Buy
3,224,293
+273,790
+9% +$22.5M 0.2% 86
2019
Q3
$237M Sell
2,950,503
-1,258,677
-30% -$101M 0.19% 89
2019
Q2
$337M Buy
4,209,180
+1,514,274
+56% +$116M 0.27% 55
2019
Q1
$214M Buy
2,694,906
+432,492
+19% +$32.3M 0.21% 80
2018
Q4
$165M Sell
2,262,414
-180,493
-7% -$12.7M 0.17% 102
2018
Q3
$165M Buy
2,442,907
+54,299
+2% +$3.46M 0.15% 113
2018
Q2
$138M Sell
2,388,608
-356,679
-13% -$20.1M 0.13% 124
2018
Q1
$143M Buy
2,745,287
+137,944
+5% +$7.45M 0.12% 135
2017
Q4
$140M Buy
2,607,343
+60,902
+2% +$3.38M 0.11% 160
2017
Q3
$156M Buy
2,546,441
+226,982
+10% +$13.8M 0.13% 118
2017
Q2
$142M Sell
2,319,459
-577,747
-20% -$35.2M 0.13% 105
2017
Q1
$176M Buy
2,897,206
+701,160
+32% +$42.5M 0.16% 79
2016
Q4
$123M Sell
2,196,046
-2,631,740
-55% -$154M 0.11% 157
2016
Q3
$288M Buy
4,827,786
+2,768,431
+134% +$162M 0.27% 47
2016
Q2
$113M Buy
2,059,355
+166,247
+9% +$8.85M 0.12% 150
2016
Q1
$95.6M Sell
1,893,108
-516,664
-21% -$25.3M 0.11% 163
2015
Q4
$121M Buy
2,409,772
+170,045
+8% +$8.57M 0.12% 140
2015
Q3
$106M Sell
2,239,727
-797,100
-26% -$42.3M 0.1% 149
2015
Q2
$165M Sell
3,036,827
-98,760
-3% -$5.54M 0.15% 102
2015
Q1
$172M Buy
3,135,587
+550,978
+21% +$31.2M 0.17% 93
2014
Q4
$140M Sell
2,584,609
-380,318
-13% -$21.2M 0.13% 147
2014
Q3
$168M Sell
2,964,927
-573,157
-16% -$32.2M 0.15% 106
2014
Q2
$195M Buy
3,538,084
+976,951
+38% +$53.3M 0.19% 75
2014
Q1
$139M Sell
2,561,133
-968,049
-27% -$50.1M 0.14% 109
2013
Q4
$169M Sell
3,529,182
-1,117,160
-24% -$51.1M 0.15% 100
2013
Q3
$211M Sell
4,646,342
-1,292,895
-22% -$59M 0.2% 65
2013
Q2
$263M Buy
+5,939,237
New +$265M 0.26% 46

Other funds holding MRK

Citigroup's MRK Position: Q2 2026 in Review

Citigroup increased its Merck (MRK) stake by 30% in Q2 2026, buying an estimated $97.8M and bringing the position to 3,614,905 shares worth $465M. The position accounts for 0.15% of the portfolio, ranked #122.

Citigroup first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $824M in Q2 2024. 3,326 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Citigroup held 3,614,905 shares of Merck worth $465M as of Q2 2026.
  • Citigroup bought 835,799 Merck shares in Q2 2026, an estimated $97.8M.
  • Merck made up 0.15% of Citigroup's portfolio in Q2 2026, its #122 holding.
  • Citigroup first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Merck position peaked at $824M in Q2 2024.
  • 3,326 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.